Vimarsana
Biggest News Aggregation in the World

Page 34 - Accessed March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed March Today - Breaking & Trending Today

Zavzpret Nasal Spray Approved for Acute Treatment of Migraine - Vimarsana News

Zavzpret Nasal Spray Approved for Acute Treatment of Migraine

The FDA has approved Zavzpret (zavegepant) nasal spray for the acute treatment of migraine with or without aura in adults.

The High Cost of Risky Business: Lessons in Vigilance from Enron, Wirecard and Silicon Valley Bank | EDRM - Electronic Discovery Reference Model - Vimarsana News

The High Cost of Risky Business: Lessons in Vigilance from Enron, Wirecard and Silicon Valley Bank | EDRM - Electronic Discovery Reference Model

[Editor’s Note: The High Cost of Risky Business: Lessons in Vigilance from Enron, Wirecard, and Silicon Valley Bank was first published March 15, 2023 on ComplexDiscovery and is...

Prostate Cancer Treatment Pluvicto Currently in Shortage - Vimarsana News

Prostate Cancer Treatment Pluvicto Currently in Shortage

Pluvicto is currently in shortage due to challenges in meeting demand and no therapeutic equivalents being available.

Empagliflozin Application for Pediatric Type 2 Diabetes Gets FDA Review - Vimarsana News

Empagliflozin Application for Pediatric Type 2 Diabetes Gets FDA Review

The FDA has accepted the sNDA for empagliflozin to improve glycemic control plus diet and exercise in patients aged ≥10 years with type 2 diabetes.

Source: empr.com
BioMarin Seeks to Expand Use of Vosoritide to Younger Children With Achondroplasia - Vimarsana News

BioMarin Seeks to Expand Use of Vosoritide to Younger Children With Achondroplasia

The FDA has accepted the sNDA for vosoritide for the treatment of children less than 5 years of age with achondroplasia.

Source: empr.com